Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › New Jersey › Clifton
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Clifton, NJ keessatti
Qorannoo 7 Luukemiya Limfoositiikii Keessummaa f Clifton fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Hackensack · Miili 7 fagaatti
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
- John Theurer Cancer Center Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Namoota walitti qabaa jiraSadarkaa 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack · Miili 7 fagaatti
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- Hackensack Meridian Health, Hackensack · Miili 7 fagaatti
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Hackensack · Miili 7 fagaatti
Study of SGR-1505 in Mature B-Cell Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Regional Cancer Care Associates, Hackensack · Miili 7 fagaatti
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 2
- Regional Cancer Care Associates /ID# 244620, Hackensack · Miili 7 fagaatti
Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Washington, DCQorannoo 22
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 19
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Cincinnati, OHQorannoo 14
- Chicago, ILQorannoo 14
Qorannoo biroo Clifton keessatti
- Kansara Qara'a Non-Small CellQorannoo 24
- Saree (Gosoota Hunda)Qorannoo 15
- Myeloma Baay’eeQorannoo 14
- Kansara MetastatikiiQorannoo 12
- Leukemia Myeloidii HamaaQorannoo 12
- Kansarii ProstateQorannoo 12
- Saree OljooQorannoo 12
- Kansarii OvariiQorannoo 11
- Dhibee QaraQorannoo 10
- Kansa EndometiriyaaliiQorannoo 8
- Kansaar Onnee Triple-NegativeQorannoo 8
- Kansarii ColorectalQorannoo 8
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.